What Surgeons Should Know About Non–Vitamin K Oral Anticoagulants: A Review
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Surgery"
DOI: 10.1001/jamasurg.2018.0374
Abstract: Importance Non–vitamin K oral anticoagulants (NOACs) are increasingly prescribed for patients to treat or prevent arterial or venous thromboembolism. The following 4 NOAC agents are approved by the US Food and Drug Administration for clinical… read more here.
Keywords: vitamin oral; noac agents; non vitamin; oral anticoagulants ... See more keywords
Non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: evidences from the real-world data
Sign Up to like & getrecommendations! Published in 2019 at "Heart Failure Reviews"
DOI: 10.1007/s10741-019-09878-y
Abstract: The role of non-vitamin K antagonist oral anticoagulants (NOACs) in stroke prevention remains unclear in Asian patients with atrial fibrillation (AF). Therefore, we performed a meta-analysis to compare the efficacy and safety outcomes of NOACs… read more here.
Keywords: non vitamin; asian patients; oral anticoagulants; antagonist oral ... See more keywords
Comparison of potential pharmacokinetic drug interactions in patients with atrial fibrillation and changing from warfarin to non-vitamin K oral anticoagulant therapy
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-021-02466-8
Abstract: There are now anticoagulant choices with proposed advantages of non-vitamin K oral anticoagulants (NOACs) over warfarin being less routine monitoring and less drug interactions. Interacting medication can impact the efficacy and safety of anticoagulant therapy… read more here.
Keywords: vitamin oral; non vitamin; drug interactions; warfarin ... See more keywords
Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity
Sign Up to like & getrecommendations! Published in 2021 at "Advances in Therapy"
DOI: 10.1007/s12325-021-01724-8
Abstract: Non-valvular atrial fibrillation (NVAF) is often accompanied by multiple comorbid conditions, which increase the associated risks and complexity of patient management. This study evaluated the risk of stroke/systemic embolism (SE) and major bleeding (MB) among… read more here.
Keywords: atrial fibrillation; risk; non vitamin; antagonist oral ... See more keywords
Non-vitamin K antagonist oral anticoagulant use at doses inappropriately lower than recommended in outpatient older adults: a real-life data
Sign Up to like & getrecommendations! Published in 2021 at "European Geriatric Medicine"
DOI: 10.1007/s41999-021-00452-0
Abstract: The purpose of this research is to determine if inappropriate NOAC prescribing is a significant problem and whether it is related to existing diseases, demographic-data, CHA2DS2-VASc and HASBLED-scores, frailty and falls. Inappropriate NOAC prescribing is… read more here.
Keywords: non vitamin; use; cardiology; antagonist oral ... See more keywords
Non-vitamin K antagonist oral anticoagulants in very elderly east Asians with atrial fibrillation: A nationwide population-based study.
Sign Up to like & getrecommendations! Published in 2020 at "American heart journal"
DOI: 10.1016/j.ahj.2020.08.006
Abstract: BACKGROUND The evidence of effectiveness and safety of the non-vitamin K antagonist oral anticoagulants (NOACs) among elderly East Asians is limited. OBJECTIVES We aimed to describe the effectiveness and safety outcomes associated with NOACs and… read more here.
Keywords: elderly east; ischemic stroke; non vitamin; antagonist oral ... See more keywords
Reversal of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in the Presence of Major Life-Threatening Bleeding.
Sign Up to like & getrecommendations! Published in 2017 at "Annals of emergency medicine"
DOI: 10.1016/j.annemergmed.2017.08.037
Abstract: Non–vitamin K antagonist oral anticoagulants (NOACs) have gained popularity as alternatives to warfarin for the prophylaxis of stroke and thromboembolic disease, as well as treatment for thromboembolic disease. This increased use is being driven by… read more here.
Keywords: non vitamin; oral anticoagulants; antagonist oral; life threatening ... See more keywords
Comparing the Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in the Elderly Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study.
Sign Up to like & getrecommendations! Published in 2019 at "Chest"
DOI: 10.1016/j.chest.2019.11.025
Abstract: BACKGROUND Stroke prevention in elderly patients with atrial fibrillation (AF) can be challenging, requiring a balance between thromboembolism prevention and serious bleeding. Comparisons of non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in the elderly,… read more here.
Keywords: atrial fibrillation; non vitamin; age; age strata ... See more keywords
The interactions between anticonvulsants and non-vitamin K antagonist oral anticoagulant agents: A systematic review
Sign Up to like & getrecommendations! Published in 2020 at "Epilepsy Research"
DOI: 10.1016/j.eplepsyres.2020.106304
Abstract: Use of non-vitamin K antagonist oral anticoagulants (NOACs), including dabigatran etexilate, rivaroxaban, apixaban, edoxaban or betrixaban provides a safe and convenient alternative to the traditional anticoagulation with vitamin K antagonists or heparin derivatives. Many patients… read more here.
Keywords: non vitamin; systematic review; antagonist oral; interactions anticonvulsants ... See more keywords
The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly.
Sign Up to like & getrecommendations! Published in 2018 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2018.02.066
Abstract: Atrial fibrillation (AF) is the most common arrhythmia and its prevalence increases with age. Age also increases the risk of thromboembolism related to AF. As a result, elderly patients are at increased risk of AF-related… read more here.
Keywords: atrial fibrillation; non vitamin; oral anticoagulants; antagonist oral ... See more keywords
Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2017.03.600
Abstract: BACKGROUND Dose reduction of non-vitamin K antagonist oral anticoagulants (NOACs) is indicated in patients with atrial fibrillation (AF) with renal impairment. Failure to reduce the dose in patients with severe kidney disease may increase bleeding… read more here.
Keywords: non vitamin; antagonist oral; renal indication; indication ... See more keywords